Surrogate antigens as targets for proteome-wide binder selection
Elin Gustavsson1, Sara Ek, Johanna Steen
1Department of Immunotechnology, Lund University, SE-221 84 Lund, Sweden.
This study demonstrates using cancer-associated protein epitope signature tags (PrESTs) as surrogate antigens for antibody selection. This approach overcomes limitations in obtaining full-length proteins for proteome-wide antibody discovery.
Area of Science:
- Biotechnology
- Immunology
- Proteomics
Background:
- Developing antibodies for proteome-wide studies and biomarker validation is crucial.
- Phage display offers advantages over traditional antibody generation methods like hybridoma technology.
- A key challenge is the limited availability of suitable antigens for proteome-wide antibody selection.
Purpose of the Study:
- To demonstrate the feasibility of using protein epitope signature tags (PrESTs) as surrogate antigens.
- To retrieve target-specific antibody binders using PrESTs in phage display selections.
- To validate the functionality of selected antibody binders for various applications.
Main Methods:
- Utilized cancer-associated PrESTs as surrogate antigens for phage display selections.
- Performed phage selections against PrESTs to identify target-specific binders.
- Validated the selected binders using western blot, immunohistochemistry, and protein microarray.
Main Results:
- Successfully demonstrated the proof of principle for using PrESTs as surrogate antigens.
- Retrieved target-specific antibody binders against various protein targets.
- Confirmed the functionality of these binders in downstream applications like western blot and immunohistochemistry.
Conclusions:
- PrESTs are a viable and accessible alternative to full-length proteins for antibody selection.
- This method facilitates the development of affinity reagents for proteome-wide studies and biomarker discovery.
- The validated binders can be applied in various research and diagnostic applications.
More Related Videos
06:01Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
Published on: January 7, 2019
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
